Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.concorddrugs.in | |
Market Cap | 31.52 Cr. | |
Enterprise Value(EV) | 46.23 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.28 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 26.45 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.43 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 34.56 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 0.98 | Calculated using Price: 33.84 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.93 Cr. | 9,315,470 Shares |
FaceValue | 10 | |
About Concord Drugs Ltd. | ||
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. |
1 Day |
|
+0.45% |
1 Week |
|
-2.34% |
1 Month |
|
-11.27% |
3 Month |
|
+22.08% |
6 Month |
|
+24.96% |
1 Year |
|
+4.44% |
2 Year |
|
+15.89% |
5 Year |
|
+39.55% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.72 | 5.37 | 12.32 | 0.94 | 1.69 | 1.92 | 1.41 | 13.06 | 5.78 | |
Return on Capital Employed (%) | 7.15 | 11.33 | 15.90 | 8.84 | 7.49 | 6.17 | 6.06 | 15.69 | 9.30 | |
Return on Assets (%) | 0.79 | 1.41 | 3.28 | 0.30 | 0.40 | 0.43 | 0.47 | 6.08 | 3.00 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 15 | 13 | 15 | 19 | 19 | 23 | 23 | 27 | 28 | 32 | |
Non Curr. Liab. | 12 | 13 | 17 | 7 | 6 | 4 | 7 | 7 | 5 | 4 | |
Curr. Liab. | 18 | 28 | 21 | 29 | 81 | 56 | 27 | 16 | 23 | 21 | |
Minority Int. | |||||||||||
Equity & Liab. | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 57 | |
Non Curr. Assets | 21 | 19 | 16 | 25 | 14 | 13 | 12 | 14 | 15 | 15 | |
Curr. Assets | 23 | 36 | 37 | 30 | 92 | 70 | 46 | 36 | 42 | 41 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 57 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 34 | 40 | 51 | 57 | 52 | 48 | 51 | 51 | 59 | 48 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 34 | 40 | 51 | 58 | 52 | 48 | 51 | 51 | 59 | 48 | |
Total Expenditure | -31 | -33 | -42 | -52 | -47 | -44 | -48 | -48 | -53 | -43 | |
PBIDT | 3 | 7 | 8 | 6 | 5 | 4 | 3 | 3 | 6 | 5 | |
Interest | -2 | -3 | -3 | -2 | -2 | -2 | -2 | -1 | -2 | -2 | |
Depreciation | -1 | -4 | -3 | -3 | -2 | -2 | -1 | -1 | -2 | -2 | |
Taxation | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | |
Exceptional Items | 4 | ||||||||||
PAT | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 2 | 1 | |
Adjusted EPS | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 4 | 2 | 1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 2 | 2 | 4 | 2 | 7 | 1 | 2 | 2 | 1 | |
Cash Fr. Inv. | -10 | -2 | -1 | 0 | -1 | -2 | 0 | -1 | -4 | 0 | |
Cash Fr. Finan. | 8 | 0 | -1 | -4 | -4 | -5 | -1 | -2 | 2 | 2 | |
Net Change | -1 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 2 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 3 |
Tue, 12 Sep 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of Newspaper Publication |
Fri, 08 Sep 2023
Intimation Of Book Closure For The Purpose Of 28Th Annual General Meeting Intimation of Book Closure for the purpose of 28th Annual General Meeting |
Fri, 08 Sep 2023
Reg. 34 (1) Annual Report. 28th Annual Report |
Mon, 25 Sep 2023 |
|
|
|
|
|